Table 4.
Subject | Baseline to Post-treatment | Baseline to 6-week F/Up | Baseline to 12-week F/Up | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||
WAB AQ | BNT | CETI | CIUs | WPM | WAB AQ | BNT | CETI | CIUs | WPM | WAB AQ | BNT | CETI | CIUs | WPM | |
Mild-Moderate | |||||||||||||||
002 (CS/LT) | 3.45 | −4 | 35.16 | −7.34 | 12.12 | 4.25 | −1 | 40.18 | 20.33 | 5.62 | 3.75 | 2 | 49.62 | 27.33 | −2.41 |
016 (LT) | −0.15 | −2 | −3.44 | 23.66 | 12.14 | 2.35 | 1 | 0.94 | 8.33 | 22.15 | 2.45 | 1 | 7.31 | −3.00 | 20.08 |
Moderate | |||||||||||||||
015 (CS/LT) | 7.00 | 9 | 16.22 | 44.66 | 16.28 | 2.50 | 10 | 19.56 | 33.33 | 9.22 | 7.80 | 18 | 15.18 | 44.66 | 6.67 |
005 (LT) | 3.95 | 12 | 21.80 | 17.33 | −13.94 | 4.95 | 12 | 33.10 | 14.33 | 13.73 | 8.25 | 11 | 21.00 | 25.66 | −4.96 |
Moderate-Severe | |||||||||||||||
014 (CS/LT) | 6.45 | −9 | Missing data | 5.67 | 9.80 | 14.55 | 1 | 35.52 | 14.00 | 6.24 | 17.35 | −2 | 37.52 | 14.33 | 4.53 |
001 (LT) | 11.90 | 6 | −16.06 | 15.34 | 20.31 | 12.20 | 11 | −3.81 | 2.34 | 4.23 | LTF | LTF | LTF | LTF | LTF |
Severe | |||||||||||||||
008 (CS/LT) | 15.00 | 10 | −0.14 | 12.00 | −1.24 | 10.60 | 11 | 23.25 | 13.66 | −2.41 | 20.30 | 15 | 20.75 | 15.00 | −4.30 |
012 (LT) | 2.65 | 0 | 41.31 | 1.33 | −23.28 | 2.65 | 0 | 34.94 | 6.67 | −22.74 | −0.50 | 0 | 30.81 | 8.33 | −12.63 |
WAB AQ – Western Aphasia Battery Aphasia Quotient; BNT – Boston Naming Test; CETI – Communicative Effectiveness Index; CIUs – Correct Information Units; WPM – Words per minute; LTF – Lost to followup